Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?

Andreas Carus; Frede Donskov; Val Gebski; Richard Kefford; Nicholas Wilcken; Rina Hui; Paul Harnett; Morten Ladekarl; Hans von der Maase; Howard Gurney

Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?

Andreas Carus, Frede Donskov, Val Gebski, Richard Kefford, Nicholas Wilcken, Rina Hui, Paul Harnett, Morten Ladekarl, Hans von der Maase, Howard Gurney

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	e21023
Journal	Journal of Clinical Oncology
Volume	29
Issue number	Suppl. 15
Number of pages	1
ISSN	0732-183X
Publication status	Published - 2011
Externally published	Yes
Event	American Society of Clinical Oncology - Chicago Duration: 7 Jun 2011 → 7 Jun 2011

Conference

Conference	American Society of Clinical Oncology
City	Chicago
Period	07/06/2011 → 07/06/2011

Access to Document

http://meeting.ascopubs.org/cgi/content/abstract/29/15_suppl/e21023?sid=9f20bb63-8aab-415c-94a1-195b379567f6

Cite this

Carus, A., Donskov, F., Gebski, V., Kefford, R., Wilcken, N., Hui, R., Harnett, P., Ladekarl, M., Maase, H. V. D., & Gurney, H. (2011). Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer? Journal of Clinical Oncology, 29(Suppl. 15), [e21023]. http://meeting.ascopubs.org/cgi/content/abstract/29/15_suppl/e21023?sid=9f20bb63-8aab-415c-94a1-195b379567f6

@article{02170777abd54daa909794522b7f2d51,

title = "Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?",

author = "Andreas Carus and Frede Donskov and Val Gebski and Richard Kefford and Nicholas Wilcken and Rina Hui and Paul Harnett and Morten Ladekarl and Maase, {Hans von der} and Howard Gurney",

year = "2011",

language = "English",

volume = "29",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "Suppl. 15",

note = "null ; Conference date: 07-06-2011 Through 07-06-2011",

}

Carus, A, Donskov, F, Gebski, V, Kefford, R, Wilcken, N, Hui, R, Harnett, P, Ladekarl, M, Maase, HVD & Gurney, H 2011, 'Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?', Journal of Clinical Oncology, vol. 29, no. Suppl. 15, e21023. <http://meeting.ascopubs.org/cgi/content/abstract/29/15_suppl/e21023?sid=9f20bb63-8aab-415c-94a1-195b379567f6>

Toxicity-adjusted dose (TAD) administration of chemotherapy : Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer? / Carus, Andreas; Donskov, Frede; Gebski, Val et al.

In: Journal of Clinical Oncology, Vol. 29, No. Suppl. 15, e21023, 2011.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Toxicity-adjusted dose (TAD) administration of chemotherapy

AU - Carus, Andreas

AU - Donskov, Frede

AU - Gebski, Val

AU - Kefford, Richard

AU - Wilcken, Nicholas

AU - Hui, Rina

AU - Harnett, Paul

AU - Ladekarl, Morten

AU - Maase, Hans von der

AU - Gurney, Howard

PY - 2011

Y1 - 2011

UR - http://meetinglibrary.asco.org/content/77876-102

M3 - Conference abstract in journal

VL - 29

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - Suppl. 15

M1 - e21023

Y2 - 7 June 2011 through 7 June 2011

ER -

Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?

Conference

Access to Document

Other files and links

Cite this